Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

By Louis Navellier and the InvestorPlace Research Staff
Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

Investing in Cannabis Stocks? 3 Marijuana Companies That Could Get a Massive Rescheduling Boost

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks to buy may be some of the most controversial investing ideas. Yet, they could also become some of the most profitable.That reality may happen…

3 Healthcare Stocks to Sell in September Before They Crash & Burn

By Noah Bolton, InvestorPlace Contributor
The healthcare industry comprises multiple sectors, including biotechnology, pharmaceuticals, and healthcare equipment, each offering a unique and potentially risky opportunity. News regarding FDA approval and…

Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?

By William White, InvestorPlace Writer
NeuBase Therapeutics (NBSE) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company.

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

By Muslim Farooque, InvestorPlace Contributor
These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.

Why Is Tilray (TLRY) Stock Up 7% Today?

By William White, InvestorPlace Writer
Tilray (TLRY) stock is climbing higher on Tuesday as investors continue to hold out hope for the decriminalization of marijuana.

Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?

By William White, InvestorPlace Writer
Helius Medical Technologies (HSDT) stock is rising higher on Tuesday as investors react to the company regaining listing compliance.

The 3 Best Stock Picks for This Week

By Michael Que, InvestorPlace Contributor
The best stock picks for this week have long-term aims such as high earnings and growth for your portfolio.

The 3 Best Biotech Stocks to Buy Now: September 2023

By Larry Ramer, InvestorPlace Contributor
Biotech stocks have underperformed in the U.S. stock market by a wide margin this year. The sector's most popular index, the iShares Biotechnology ETF (NASDAQ:IBB),…

Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game

By John Blankenhorn, InvestorPlace Contributor
Robotics will upend laboratory research just as they upended factories. Bet on the future with these 3 robo-lab company stocks.

7 F-Rated Meme Stocks to Avoid Like the Plague

By Louis Navellier and the InvestorPlace Research Staff
These popular meme stocks should be avoided at all costs – no matter what you may see on social media.

7 Up-and-Coming Penny Stocks to Put on Your Must-Buy List

By Thomas Niel, InvestorPlace Contributor
So, what are some of the best up-and-coming penny stocks to buy right now? Take a look at these seven. Very attractive in terms of valuation and growth potential, each one is a strong opportunity at today's prices.

Tilray’s Cannabis Beverage Move: Is It Time to Buy, Hold or Sell?

By Chris MacDonald, InvestorPlace Contributor
The question of whether cannabis infused beverages are the future, or if these will be another loss leader for Tilray, is a good one.

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

By John Blankenhorn, InvestorPlace Contributor
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.

The 3 Most Promising Healthcare Stocks to Own Now

By Charles Munyi, InvestorPlace Contributor
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

7 Undervalued Stocks Due for a Massive Short Squeeze

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued short squeeze candidates that are poised for multibagger returns

Safe Haven Alert: 3 Value Stocks to Guard Against Bull Market Uncertainties

By Rich Duprey, InvestorPlace Contributor
The stock market is in the midst of a pretty remarkable run. After collapsing almost 20% last year, the S&P 500 is up 26% from…

3 Biotech Stocks Due for a Massive Short Squeeze

By Faisal Humayun, InvestorPlace Contributor
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.

TLRY Stock Alert: Watch This Upside Catalyst for Tilray Closely

By Larry Ramer, InvestorPlace Contributor
A drug scheduling change reportedly recommended by the Department of Health and Human Services has sparked a rally in TLRY stock.
Load More Articles